First National Bank Of Hutchinson Bristol Myers Squibb CO Transaction History

First National Bank Of Hutchinson

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 20, 2021	SELL	$59.17 - $69.31 $473,004 - $554,064	-7,994 Closed	0 $0
Q2 2021 Jul 27, 2021	SELL	$61.91 - $67.42 $93,546 - $101,871	-1,511 Reduced 15.9%	7,994 $534,000
Q1 2021 Apr 14, 2021	BUY	$59.34 - $66.74 $153,571 - $172,723	2,588 Added 37.42%	9,505 $600,000
Q4 2020 Feb 05, 2021	BUY	$57.74 - $65.43 $87,360 - $98,995	1,513 Added 28.0%	6,917 $425,000
Q3 2020 Feb 08, 2021	BUY	$57.43 - $63.64 $2,641 - $2,927	46 Added 0.86%	5,404 $326,000
Q2 2020 Feb 08, 2021	BUY	$54.82 - $64.09 $1,754 - $2,050	32 Added 0.6%	5,358 $315,000
Q1 2020 May 06, 2020	BUY	$46.4 - $67.43 $27,979 - $40,660	603 Added 12.77%	5,326 $297,000
Q4 2019 Jan 31, 2020	BUY	$49.21 - $64.19 $232,418 - $303,169	4,723 New	4,723 $303,000

2,399

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $106B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of First National Bank Of Hutchinson, based on Form 13F filings with the SEC.

Stay updated on First National Bank Of Hutchinson with notifications on news.